Synergistic Effect of H1-Antihistamines on Topical Corticosteroids for Pruritus in Atopic Dermatitis: A Systematic Review and Meta-Analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Although oral antihistamines (H1-histamine receptor antagonists) are the main treatment option for pruritus in general skin dermatosis, their effect in treating pruritus of atopic dermatitis (AD) has not yet been established. Objective: We conducted a systematic review and meta-analysis to evaluate the effectiveness of combined therapy of H1-antihistamines and topical steroids. Methods: We systematically searched MEDLINE, Embase, and CENTRAL databases for articles published from 1967 to 2015. We identified 1,206 studies and assessed their titles, abstract, and full-text. Random effects meta-analysis was used to calculate mean differences (MD) with 95% confidence intervals (CI). Results: Two studies satisfying the inclusion criteria of antihistamine therapy with mandatory topical steroid use were selected. Comparing antihistamine monotherapy with combination therapy, patients treated with the addition of antihistamine to topical corticosteroids showed a statistically significant clinical improvement (standard MD, −0.24; 95% CI, −0.42 to −0.05; p=0.01). Conclusion: H1-antihistamines may have a synergistic effect when combined with topical steroids by influencing various associative factors of chronic pruritus in AD.
Abstract
Background: Although oral antihistamines (H1-histamine receptor antagonists) are the main treatment option for pruritus in general skin dermatosis, their effect in treating pruritus of atopic dermatitis (AD) has not yet been established. Objective: We conducted a systematic review and meta-analysis to evaluate the effectiveness of combined therapy of H1-antihistamines and topical steroids. Methods: We systematically searched MEDLINE, Embase, and CENTRAL databases for articles published from 1967 to 2015. We identified 1,206 studies and assessed their titles, abstract, and full-text. Random effects meta-analysis was used to calculate mean differences (MD) with 95% confidence intervals (CI). Results: Two studies satisfying the inclusion criteria of antihistamine therapy with mandatory topical steroid use were selected. Comparing antihistamine monotherapy with combination therapy, patients treated with the addition of antihistamine to topical corticosteroids showed a statistically significant clinical improvement (standard MD, −0.24; 95% CI, −0.42 to −0.05; p=0.01). Conclusion: H1-antihistamines may have a synergistic effect when combined with topical steroids by influencing various associative factors of chronic pruritus in AD.
참고문헌 (29)
- Apfelbacher CJ, "Oral H1 antihistamines as monotherapy for eczema", Cochrane Database Syst Rev, (2) (2013)
- Church MK, "H1-antihistamines and itch in atopic dermatitis", Exp Dermatol, 24, pp.332~333 (2015)
- 김정은, "Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment", Annals of Dermatology, 27(5), pp.563~577 (2015), 대한피부과학회
- Kawashima M, "Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study", Br J Dermatol, 148, pp.1212~1221 (2003)
- Chunharas A, "Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream", J Med Assoc Thai, 85, pp.482~487 (2002)
- Yosipovitch G, "What causes itch in atopic dermatitis", Curr Allergy Asthma Rep, 8, pp.306~311 (2008)
- Raap U, "IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis", Pediatr Allergy Immunol, 23, pp.285~288 (2012)
- Sonja Grundmann, "Chronic Pruritus: Clinics and Treatment", Annals of Dermatology, 23(1), pp.1~11 (2011), 대한피부과학회
- Yosipovitch G, "The brain processing of scratching", J Invest Dermatol, 128, pp.1806~1811 (2008)
- Krause L, "Mechanism of action of antipruritic drugs", Br Med J(Clin Res Ed), 287, pp.1199~1200 (1983)
- Cook EB, "Olopatadine inhibits TNFalpha release from human conjunctival mast cells", Ann Allergy Asthma Immunol, 84, pp.504~508 (2000)
- Yanni JM, "Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs", Arch Ophthalmol, 117, pp.643~647 (1999)
- Murota H, "Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model", Acta Derm Venereol, 94, pp.78~79 (2014)
- Tamura T, "Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2, 4-diisocyanate in rats", Int Immunopharmacol, 8, pp.916~921 (2008)
- Bocşan CI, "In vivo anti-inflammatory effect of H1antihistamines in allergic rhinitis : a randomized clinical trial", Balkan Med J, 32, pp.352~358 (2015)
- Başak PY, "Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria", Int J Dermatol, 53, pp.1526~1530 (2014)
- Lipnik-Stangelj M, "Activation of histamine H1-receptor enhances neurotrophic factor secretion from cultured astrocytes", Inflamm Res, 53, pp.245~252 (2004)
- Ali MA, "Topical steroid therapy induces protolerogenic changes in Langerhans cells in human skin", Immunology, 146, pp.411~422 (2015)
- Zhu L, "Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model", Mol Vis, 18, pp.1803~1812 (2012)
- Aksoy MO, "Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells", J Allergy Clin Immunol, 103, pp.1081~1091 (1999)
- Matsui K, "Betamethasone, but not tacrolimus, suppresses the development of Th2 cells mediated by Langerhans cell-like dendritic cells", Biol Pharm Bull, 39, pp.1220~1223 (2016)
- Lee HK, "1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients", Ophthalmology, 113, pp.198~205 (2006)
- Kagawa Y, "Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice", Pharmacology, 85, pp.286~294 (2010)
- Bigliardi-Qi M, "Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis", Dermatology, 210, pp.91~99 (2005)
- Arndt J, "Stress and atopic dermatitis", Curr Allergy Asthma Rep, 8, pp.312~317 (2008)
- Bigliardi PL, "Treatment of pruritus with topically applied opiate receptor antagonist", J Am Acad Dermatol, 56, pp.979~988 (2007)
- Yoshida A, "Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors : a study in histidine decarboxylase gene knockout mice", Eur J Pharmacol, 522, pp.55~62 (2005)
- Nakasone T, "The interaction between histamine H1 receptor and μ-opioid receptor in scratching behavior in ICR mice", Eur J Pharmacol, 777, pp.124~128 (2016)
- Sugimoto Y, "Effects of histamine H1 receptor antagonists on compound 48", 80-induced scratching behavior in mice, 1998, pp.351, 1~5